RxSight, Inc. (RXST)

NASDAQ: RXST · IEX Real-Time Price · USD
16.40
-0.27 (-1.62%)
Mar 27, 2023, 4:00 PM EDT - Market closed

Ratios and Metrics (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year Current2022202120202019
Market Capitalization
554351308--
Market Cap Growth
-14.14%---
Enterprise Value
492290193-39-76
PE Ratio
-5.26-5.26-6.32--
PS Ratio
11.307.1713.62--
PB Ratio
6.163.912.23--
P/FCF Ratio
-5.74-5.74-6.60--
P/OCF Ratio
-5.97-5.97-6.88--
EV/Sales Ratio
10.055.918.52-2.64-33.92
EV/EBITDA Ratio
-5.01-5.01-4.69-1.20-0.58
EV/EBIT Ratio
-4.69-4.69-4.28-1.37-0.60
EV/FCF Ratio
-4.73-4.73-4.131.031.72
Debt / Equity Ratio
0.500.500.33-0.07-0.01
Debt / EBITDA Ratio
-0.78-0.78-1.100.960.04
Debt / FCF Ratio
-0.73-0.73-0.96-0.81-0.13
Current Ratio
7.817.8115.927.0310.67
Asset Turnover
0.300.300.150.14-
Return on Equity (ROE)
-63.70%-63.70%59.70%-0.80%-
Return on Assets (ROA)
-41.10%-41.10%-33.10%3.20%-
Return on Capital (ROIC)
-35.30%-35.30%-32.20%27.60%-
Earnings Yield
-12.05%-19.01%-15.82%--
FCF Yield
-11.06%-17.44%-15.16%--
Buyback Yield / Dilution
-103.02%-103.02%-146.28%--
Total Shareholder Return
-103.02%-103.02%-146.28%--
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).